This document provides an overview of the medicines' safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during Jul - Sep 2024. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...
This document provides an overview of the medicines' safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during Oct - Dec 2024. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...
This document provides an overview of the medicines' safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during Apr - Jun 2025. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...
This document provides an overview of the medicines' safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during Jan - Mar 2025. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...
The aim of this newsletter is to disseminate regulatory information on post-marketing surveillance and pharmacovigilance activities rendered by SAHPRA, which includes responsibilities of the SAHPRA Pharmacovigilance unit, reporting tools and pharmacovigilance systems in the country....
This document provides an overview of the medicines safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during January – March 2024. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...
This document provides an overview of the medicines safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during October – December 2023. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...
This document provides an overview of the medicines safety regulatory decisions made by the South African Health Products Regulatory Authority (SAHPRA) during October – December 2023. This includes decisions where safety concerns were reviewed and concluded, as well as those safety concerns that remain unresolved...
SAHPRA requests electronic submission of the latest PSMF by 12 November 2025, including PV staffing details and a list of registered and marketed products. Submit via email to GVP@sahpra.org.za with the specified subject line....
Adcock Ingram Limited, in collaboration with the South African Health Products Regulatory Authority (SAHPRA), would like to inform you of the amended product labelling for Corenza-C® Effervescent Tablets to align with the recommended contraindicated use of aspirin in children under the age of 12 years...